id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2132454,84dadea6-e91a-41f2-bcf3-7d3511e699d6,Q1,BIOTECHNOLOGY INNOVATION ORGANIZATION,6245,BIOTECHNOLOGY INNOVATION ORGANIZATION,2018,first_quarter,SMB,"Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions
---H.R. 10: Financial Choice Act

Proxy Advisory Services
---Impact of Policies on Small Public Companies
---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017
---H.R. 10: Financial Choice Act

Sarbanes Oxley Section 404 (b)
---H.R. 1645/S. 2126: Fostering Innovation Act

Short Selling Transparency

Small Business Intellectual Property Training
---H.R. 2655: Small Business Innovation Protection Act 

XBRL Exemption for Small Public Companies
---H.R. 5054: Small Company Disclosure Simplification Act 
---H.R. 10: Financial Choice Act","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Natl Institutes of Health (NIH),Natl Security Council (NSC),Office of Management & Budget (OMB),Securities & Exchange Commission (SEC),SENATE,U.S. Trade Representative (USTR),White House Office",,2370000,0,0,2018-04-20T16:46:32.980000-04:00